[1]
Sherman, S.I. Thyroid carcinoma. Lancet, 2003, 361(9356), 501-511.
[2]
Davies, L.; Welch, H.G. Current thyroid cancer trends in the United States. JAMA Otolaryngol. Head Neck Surg., 2014, 140(4), 317-322.
[3]
Leenhardt, L.; Bernier, M.O.; Boin-Pineau, M.H.; Conte Devolx, B.; Marechaud, R.; Niccoli-Sire, P.; Nocaudie, M.; Orgiazzi, J.; Schlumberger, M.; Wemeau, J.L.; Cherie-Challine, L.; De Vathaire, F. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur. J. Endocrinol., 2004, 150(2), 133-139.
[4]
Kouvaraki, M.A.; Shapiro, S.E.; Fornage, B.D.; Edeiken-Monro, B.S.; Sherman, S.I.; Vassilopoulou-Sellin, R.; Lee, J.E.; Evans, D.B. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery, 2003, 134(6), 946-954.
[5]
Barczynski, M.; Konturek, A.; Stopa, M.; Nowak, W. Prophylactic central neck dissection for papillary thyroid cancer. Br. J. Surg., 2013, 100(3), 410-418.
[6]
Youssef, T.; Gaballah, G.; Abd-Elaal, E.; El-Dosoky, E. Assessment of risk factors of incidental parathyroidectomy during thyroid surgery: a prospective study. Int. J. Surg., 2010, 8(3), 207-211.
[7]
Catarci, M.; Guadagni, S.; Zaraca, F.; Pistoia, M.A.; Mastracchio, A.; Trecca, A.; Ruco, L.; Carboni, M. Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer. Ann. Surg. Oncol., 1998, 5(7), 580-584.
[8]
Cai, H.K.; He, H.F.; Tian, W.; Zhou, M.Q.; Hu, Y.; Deng, Y.C. Colorectal cancer lymph node staining by activated carbon nanoparticles suspension in vivo or methylene blue in vitro. World J. Gastroenterol., 2012, 18(42), 6148-6154.
[9]
Yezhelyev, M.V.; Gao, X.; Xing, Y.; Al-Hajj, A.; Nie, S.; O’Regan, R.M. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol., 2006, 7(8), 657-667.
[10]
Zhu, Y.; Chen, X.; Zhang, H.; Chen, L.; Zhou, S.; Wu, K.; Wang, Z.; Kong, L.; Zhuang, H. Carbon nanoparticle-guided central lymph node dissection in clinically node-negative patients with papillary thyroid carcinoma. Head Neck, 2016, 38(6), 840-845.
[11]
Hao, R.T.; Chen, J.; Zhao, L.H.; Liu, C.; Wang, O.C.; Huang, G.L.; Zhang, X.H.; Zhao, J. Sentinel lymph node biopsy using carbon nanoparticles for Chinese patients with papillary thyroid microcarcinoma. Eur. J. Surg. Oncol., 2012, 38(8), 718-724.
[12]
White, M.L.; Gauger, P.G.; Doherty, G.M. Central lymph node dissection in differentiated thyroid cancer. World J. Surg., 2007, 31(5), 895-904.
[13]
Cernea, C.R.; Brandao, L.G.; Hojaij, F.C.; De Carlucci, D.; Montenegro, F.L.; Plopper, C.; Vanderlei, F.; Gotoda, R.; Dias, F.L.; Lima, R.A. How to minimize complications in thyroid surgery? Auris Nasus Larynx, 2010, 37(1), 1-5.
[14]
Harari, A.; Sippel, R.S.; Goldstein, R.; Aziz, S.; Shen, W.; Gosnell, J.; Duh, Q.Y.; Clark, O.H. Successful localization of recurrent thyroid cancer in reoperative neck surgery using ultrasound-guided methylene blue dye injection. J. Am. Coll. Surg., 2012, 215, 555-561.
[15]
Hillary, S.L.; Guillermet, S.; Brown, N.J.; Balasubramanian, S.P. Use of methylene blue and near-infrared fluorescence in thyroid and parathyroid surgery. Langenbeck Arch. Surg., 2018, 403, 111-118.
[16]
Li, Y.; Jian, W.H.; Guo, Z.M.; Li, Q.L.; Lin, S.J.; Huang, H.Y. A Meta-analysis of carbon nanoparticles for identifying lymph nodes and protecting parathyroid glands during surgery. Otolaryngol. Head Neck Surg., 2015, 152(6), 1007-1016.
[17]
Liu, F.; Zhu, Y.; Qian, Y.; Zhang, J.; Zhang, Y.; Zhang, Y. Recognition of sentinel lymph nodes in patients with papillary thyroid cancer by nano-carbon and methylene blue. Pak. J. Med. Sci., 2017, 33(6), 1485-1489.
[18]
Chaojie, Z.; Shanshan, L.; Zhigong, Z.; Jie, H.; Shuwen, X.; Peizhi, F.; Jing, X.; Xiaowen, G.; Yang, L.; Wei, Z. Evaluation of the clinical value of carbon nanoparticles as lymph node tracer in differentiated thyroid carcinoma requiring reoperation. Int. J. Clin. Oncol., 2016, 21(1), 68-74.
[19]
Hagiwara, A.; Takahashi, T.; Sawai, K.; Iwamoto, A.; Shimotsuma, M.; Yoneyama, C.; Seiki, K.; Itoh, M.; Sasabe, T.; Lee, M. Lymph nodal vital staining with newer carbon particle suspensions compared with India ink: Experimental and clinical observations. Lymphology, 1992, 25(2), 84-89.
[20]
Yu, W.; Cao, X.; Xu, G.; Song, Y.; Li, G.; Zheng, H.; Zhang, N. Potential role for carbon nanoparticles to guide central neck dissection in patients with papillary thyroid cancer. Surgery, 2016, 160(3), 755-761.
[21]
Sun, S.P.; Zhang, Y.; Cui, Z.Q.; Chen, Q.; Zhang, W.; Zhou, C.X.; Xie, P.P.; Liu, B.G. Clinical application of carbon nanoparticle lymph node tracer in the VI region lymph node dissection of differentiated thyroid cancer. Genet. Mol. Res., 2014, 13(2), 3432-3437.
[22]
Kihara, M.; Miyauchi, A.; Kontani, K.; Yamauchi, A.; Yokomise, H. Recovery of parathyroid function after total thyroidectomy: long-term follow-up study. ANZ J. Surg., 2005, 75(7), 532-536.
